Work

Fluorescence imaging agents in cancerology

Year: 2010

Type: article

Abstract: BACKGROUND: One of the major challenges in cancer therapy is to improve early detection and prevention using novel targeted cancer diagnostics. Detection requests specific recognition. Tumor markers have to be ideally present on the surface of cancer cells. Their targeting with ligands coupled to imaging agents make them visible/detectable. CONCLUSIONS: Fluorescence imaging is a newly emerging technology which is becoming a complementary medical method for cancer diagnosis. It allows detection with a high spatio-temporal resolution of tumor markers in small animals and in clinical studies. In this review, we focus on the recent outcome of basic studies in the design of new approaches (probes and devices) used to detect tumor cells by fluorescence imaging.

Source: Radiology and Oncology

DOI: 10.2478/v10019-010-0031-y

Authors: Aurélie Paganin-Gioanni, Elisabeth Bellard, Laurent Paquereau, Vincent Ecochard, Muriel Golzio, Justin Teissié

Institutions: Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale, Université Toulouse III - Paul Sabatier, Université de Toulouse

Language: English

Topic: Nanoplatforms for cancer theranostics

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $970